Coronary Artery Bypass Graft Surgery
Evolocumab may reduce likelihood of future revascularization in established ASCVD
Evolocumab, a PCSK9 inhibitor, in addition to statin therapy for stable atherosclerotic CVD may lower risk for future revascularization with PCI or CABG, according to findings published in the Journal of the American College of Cardiology.
Multiple arterial grafting in CABG may confer poorer outcomes in women vs. men
Multiple arterial grafts during CABG were associated with better mortality vs. single multiple arterial grafting, but women experienced worse mortality and risk for major adverse events compared with men, researchers reported.
CABG, surgical AVR may be safe despite flu season severity, duration
CABG or surgical AVR procedures may be safe to perform even in the worst of influenza seasons, according to research published in JAMA Network Open.
Lower LDL confers fewer events in patients with CHD, diabetes eligible for PCI, CABG
Lower LDL levels were associated with fewer adverse events among patients with CHD and type 2 diabetes eligible for PCI or CABG, according to results published in the Journal of the American College of Cardiology.
POPular CABG
Saphenous vein graft occlusion, graft failure and bleeding with aspirin plus ticagrelor (Brilinta, AstraZeneca) after CABG compared with aspirin alone.
Procedural MI rates during revascularization vary widely based on definition
In two trials comparing outcomes of PCI with CABG, rates of procedural MI varied greatly depending on which definition was used, according to two analyses published in the Journal of the American College of Cardiology.
DAPT with ticagrelor after CABG confers similar outcomes to aspirin alone at 1 year
At 1 year, aspirin plus ticagrelor after CABG was associated with similar saphenous vein graft occlusion, graft failure and bleeding compared with aspirin alone, according to results from the POPular CABG trial.
Heart team often opposes treating interventionalist’s strategy for multivessel CAD
An analysis of the team approach to decision-making for multivessel CAD indicated that the consensus of a heart team was discordant with patients’ original treating interventionalist in nearly one-third of cases, researchers reported.
Opium consumption after CABG increases risk for mortality, CVD events
The risk for mortality, ACS and major adverse cardio-cerebrovascular events increased throughout 5 years in patients who continued opium consumption after CABG, researchers found.
CABG bests PCI in most patients with chronic total occlusion, multivessel disease
In a retrospective study of patients with chronic total occlusion and multivessel CAD, CABG conferred better long-term outcomes than PCI, according to data presented at the virtual PCR e-Course.